Bell Asset Management LTD Charles River Laboratories International, Inc. Transaction History

Bell Asset Management LTD

$538 Million
Q3 2024

A detailed history of Bell Asset Management LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Bell Asset Management LTD holds 29,171 shares of CRL stock, worth $5.48 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares

29,171

Previous 44,817 34.91%

Holding current value

$5.48 Million

Previous $9.26 Million 37.93%

% of portfolio

1.07%

Previous 1.31%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$187.96 - $245.29 $2.94 Million - $3.84 Million	-15,646 Reduced 34.91%	29,171 $5.75 Million
Q2 2024 Aug 13, 2024	BUY	$206.39 - $268.73 $1.27 Million - $1.65 Million	6,145 Added 15.89%	44,817 $9.26 Million
Q1 2024 May 14, 2024	SELL	$203.52 - $273.43 $970,179 - $1.3 Million	-4,767 Reduced 10.97%	38,672 $10.5 Million
Q4 2023 Feb 13, 2024	SELL	$164.52 - $238.84 $1.13 Million - $1.64 Million	-6,868 Reduced 13.65%	43,439 $10.3 Million
Q3 2023 Nov 13, 2023	BUY	$194.44 - $217.61 $856,119 - $958,136	4,403 Added 9.59%	50,307 $9.86 Million
Q2 2023 Aug 11, 2023	BUY	$183.71 - $210.25 $789,218 - $903,234	4,296 Added 10.32%	45,904 $9.65 Million
Q1 2023 May 12, 2023	SELL	$191.89 - $259.92 $47,588 - $64,460	-248 Reduced 0.59%	41,608 $8.4 Million
Q4 2022 Feb 13, 2023	SELL	$197.11 - $250.07 $77,070 - $97,777	-391 Reduced 0.93%	41,856 $9.12 Million
Q3 2022 Nov 10, 2022	BUY	$182.44 - $250.54 $475,256 - $652,656	2,605 Added 6.57%	42,247 $8.31 Million
Q2 2022 Aug 12, 2022	BUY	$204.13 - $302.4 $1.7 Million - $2.52 Million	8,349 Added 26.68%	39,642 $8.48 Million
Q1 2022 May 13, 2022	BUY	$255.51 - $362.11 $1.76 Million - $2.49 Million	6,885 Added 28.21%	31,293 $8.89 Million
Q4 2021 Feb 11, 2022	BUY	$351.38 - $448.68 $2.81 Million - $3.58 Million	7,983 Added 48.6%	24,408 $9.2 Million
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $323,451 - $397,804	-868 Reduced 5.02%	16,425 $6.78 Million
Q2 2021 Aug 13, 2021	SELL	$294.17 - $371.65 $26,769 - $33,820	-91 Reduced 0.52%	17,293 $6.4 Million
Q1 2021 May 14, 2021	SELL	$249.67 - $299.48 $1.01 Million - $1.21 Million	-4,047 Reduced 18.88%	17,384 $5.04 Million
Q4 2020 Feb 12, 2021	BUY	$222.0 - $252.62 $245,088 - $278,892	1,104 Added 5.43%	21,431 $5.36 Million
Q3 2020 Nov 13, 2020	SELL	$175.56 - $226.45 $752,976 - $971,244	-4,289 Reduced 17.42%	20,327 $4.6 Million
Q2 2020 Aug 13, 2020	SELL	$118.84 - $189.72 $2.04 Million - $3.26 Million	-17,197 Reduced 41.13%	24,616 $4.29 Million
Q1 2020 May 14, 2020	BUY	$98.9 - $178.34 $865,276 - $1.56 Million	8,749 Added 26.46%	41,813 $5.28 Million
Q4 2019 Feb 13, 2020	BUY	$126.05 - $152.76 $4.17 Million - $5.05 Million	33,064 New	33,064 $5.05 Million

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Bell Asset Management LTD with notifications on news.

Account

Bell Asset Management LTD Charles River Laboratories International, Inc. Transaction History